• Cryo-Cell posted fiscal Q2 2026 revenue of USD 7.8 million, down 2% from the year-earlier quarter.
• Net income rose to USD 555,000, or USD 0.07 per share, from USD 356,000, or USD 0.04 per share.
• Processing and storage fee revenue slipped to USD 7.71 million; public banking revenue increased to USD 46,000.
• Product revenue was flat at USD 14,000, while the quarter’s revenue decline was driven by lower processing and storage fees.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cryo-Cell International Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260715354031) on July 15, 2026, and is solely responsible for the information contained therein.